Cargando…
Dextran-70 to modulate inflammatory response after cardiopulmonary bypass: potential for a novel approach?
Potential deleterious effects of cardiopulmonary bypass (CPB) and cardioplegic cardiac arrest are known to influence outcome. The inflammatory response after CPB may have unfavourable effects especially in high-risk patients, for example, the very elderly. Thus, to blunt the release of pro-inflammat...
Autores principales: | Schuerholz, Tobias, Marx, Gernot |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556734/ https://www.ncbi.nlm.nih.gov/pubmed/17850682 http://dx.doi.org/10.1186/cc6103 |
Ejemplares similares
-
Fluid-induced coagulopathy: does the type of fluid make a difference?
por: Marx, Gernot, et al.
Publicado: (2010) -
Antimicrobial peptides and their potential application in inflammation and sepsis
por: Schuerholz, Tobias, et al.
Publicado: (2012) -
Detrimental effect of cardiopulmonary bypass(CPB) on malignant disease
por: Darwazah, Ahmad K, et al.
Publicado: (2011) -
Commentary: Taking the next step in cardiopulmonary bypass management
por: Lodge, Andrew J., et al.
Publicado: (2020) -
Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery
por: Schneider, Christian P, et al.
Publicado: (2010)